PTC Therapeutics, Inc. (PTCT)
70.76
+3.11
(+4.60%)
USD |
NASDAQ |
May 27, 15:52
PTC Therapeutics Free Cash Flow : -516.78M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Sarepta Therapeutics, Inc. | 91.18M |
| Keros Therapeutics, Inc. | -58.25M |
| Insmed, Inc. | -951.64M |
| Madrigal Pharmaceuticals, Inc. | -275.41M |
| Protagonist Therapeutics, Inc. | -117.90M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -59.04M |
| Cash from Investing (Quarterly) | -93.74M |
| Cash from Financing (Quarterly) | 6.403M |
| Free Cash Flow Per Share (Quarterly) | -0.7319 |
| Free Cash Flow to Equity (Quarterly) | -56.78M |
| Free Cash Flow to Firm (Quarterly) | -4.455M |
| Free Cash Flow Yield | -8.89% |